Newsletter Archive

11. 01.20.21 -- FDA FY2020 Drug Inspection Observations And Trends 1/20/2021
    01/20/21 BioProcess Online Newsletter
12. 01.19.21 -- Overcoming Cell And Gene Commercialization Challenges 1/19/2021
    01/19/21 BioProcess Online Newsletter
13. 01.18.21 -- Slow-Walking The Isolator: A Cautionary Tale 1/18/2021
    01/18/21 BioProcess Online Newsletter
14. 01.15.21 -- New Year, New Podcast Episodes: Clinical Trials During A Pandemic; Gene Therapies At Scale 1/15/2021
    01/15/21 BioProcess Online Newsletter
15. 01.14.21 -- Tips For Delivering Biologics Therapies To Market Faster 1/14/2021
    01/14/21 BioProcess Online Newsletter
16. 01.13.21 -- How To Create A Connected mAb Perfusion Process 1/13/2021
    01/13/21 BioProcess Online Newsletter
17. 01.13.21 -- Managing Quality, cGMP Compliance Capability Of CMOs 1/13/2021
    01/13/21 BioProcess Online Newsletter
18. 01.12.21 -- Considerations For CDMO Selection For Large Molecule Drug Development 1/12/2021
    01/12/21 BioProcess Online Newsletter
19. 01.12.21 -- Advances In COVID-19 Vaccine Development | Emergence Of An mRNA Vaccine Platform 1/12/2021
    01/12/21 BioProcess Online Newsletter
20. 01.11.21 -- The AAV Vector Challenge With Selecta's Dr. Carsten Brunn 1/11/2021
    01/11/21 BioProcess Online Newsletter